Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BLM | P54132 | 1/20 | 0.91 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | BHMT | Q93088 | 1/20 | 0.37 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL716925 | 0.95 | BLM (1.00) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL26624410 | 0.95 | BLM (1.00) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL11600716 | 0.95 | BLM (1.00) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL27489073 | 0.95 | BLM (0.83) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL23673151 | 0.91 | BLM (0.92) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL11879730 | 0.91 | BLM (0.83) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL6254815 | 0.88 | BLM (0.86) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL27489069 | 0.88 | BLM (0.71) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL276749 | 0.88 | BLM (0.86) | BLMACE2LMNAGABRR1CYP1A2 | |
| SCHEMBL6249628 | 0.88 | BLM (0.86) | BLMACE2LMNAGABRR1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1310872-C | Mono- and disubstituted 3-propyl gamma-aminobutyric acids | WARNER LAMBERT CO (US) | 2007-04-18 | — | — | CN | claimed |
| CN-1355784-A | Mono-and disubstituted 3-propyl-gamma-aminobutyric acids | WARNER LAMBERT CO (US) | 2002-06-26 | — | — | CN | claimed |
| CN-101862317-A | The pregabalin derivant that is used for the treatment of fibromyalgia and other disease | WARNER LAMBERT CO | 2010-10-20 | — | — | CN | disclosed |
| CN-101283995-A | Different pharmaceutical uses alpha2delta ligands | WARNER LAMBERT CO (US) | 2008-10-15 | — | — | CN | disclosed |
| CN-1310872-C | Mono- and disubstituted 3-propyl gamma-aminobutyric acids | WARNER LAMBERT CO (US) | 2007-04-18 | — | — | CN | disclosed |
| CN-1878546-A | Combination comprising an alpha-2 delta ligand and an SSRI and/or SNRI for the treatment of depression and anxiety | WARNER LAMBERT CO (US) | 2006-12-13 | — | — | CN | disclosed |
| US-6992057-B2 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY (US) | 2006-01-31 | — | — | US | disclosed |
| CN-1726015-A | Alpha 2 delta ligands for different pharmaceutical uses | WARNER LAMBERT CO (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1726023-A | Pregabalin derivatives for the treatment of fibromyalgia and other diseases | WARNER LAMBERT CO (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1678298-A | Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder | WARNER LAMBERT CO (US) | 2005-10-05 | — | — | CN | disclosed |
| US-6949502-B2 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY (US) | 2005-09-27 | — | — | US | disclosed |
| US-20040092418-A1 | Fatty acids, soaps surfactant systems, and consumer products based thereon | CONNOR DANIEL STEDMAN (US) | 2004-05-13 | — | — | US | disclosed |
| US-20040087461-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2004-05-06 | — | — | US | disclosed |
| US-20030236180-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2003-12-25 | — | — | US | disclosed |
| US-6602845-B2 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | THE PROCTER & GAMBLE COMPANY | 2003-08-05 | — | — | US | disclosed |
| US-20030100469-A1 | Fatty acids, soaps, surfactant systems, and consumer products based thereon | CONNOR DANIEL STEDMAN (US) | 2003-05-29 | — | — | US | disclosed |
| CN-1355784-A | Mono-and disubstituted 3-propyl-gamma-aminobutyric acids | WARNER LAMBERT CO (US) | 2002-06-26 | — | — | CN | disclosed |
| US-6395701-B1 | MIXTURE | PROCTER & GAMBLE COMPANY, THE | 2002-05-28 | — | — | US | disclosed |
| EP-1025190-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 2000-08-09 | — | — | EP | disclosed |
| WO-1999020722-A2 | FATTY ACIDS, SOAPS, SURFACTANT SYSTEMS, AND CONSUMER PRODUCTS BASED THEREON | THE PROCTER & GAMBLE COMPANY (US) | 1999-04-29 | — | — | WO | disclosed |